ArticleNPJ precision oncology2021
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis.
Arlou Kristina Angeles et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it